Prognosis and Integrative Assessment of Aortic Coarctation Patients in China

NCT04011956 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-07-14

No results posted yet for this study

Summary

This is a systemic research of Chinese aortic coarctation patients, aiming to determine risk factors and serial biomarkers of aortic coarctation in prognosis.

Conditions

  • Coarctation of Aorta

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    collaborator OTHER
  • Bayi Children's Hospital Affiliated to PLA Army General Hospital, China

    collaborator OTHER
  • Capital Institute of Pediatrics, China

    collaborator OTHER
  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie DU, PhD · Beijing Institute of Heart, Lung and Blood Vessel Diseases

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04011956 on ClinicalTrials.gov